RISK: Health, Safety & Environment (1990-2002)


Dr. Murashige addresses the need for a patent system more closely tailored to the needs of biotechnology. For example, the obviousness requirement may interfere with using patents to recoup high costs of work when it could arguably be done by researchers of ordinary skill.

Repository Citation

Kate H. Murashige, Genome Research and Traditional Intellectual Property Protection -- A Bad Fit, 7 RISK 231 (1996).